Marshall Urist, MD, Ph.D.
, has been named vice president of Research and Investments at Royalty Pharma
. Dr. Urist joins the company from Morgan Stanley, where he spent the last eight years at in equity research, most recently as executive director and senior biotechnology analyst covering the life science tools and diagnostics sectors.
"We are excited to have Marshall join our team. He has had a distinguished career on Wall Street, and this experience coupled with his deep analytical skills make him an excellent addition to Royalty Pharma," said Pablo Legorreta, founder and chief executive officer of Royalty Pharma.